Cargando…
Growth arrest and forced differentiation of human primary glioblastoma multiforme by a novel small molecule
Glioblastoma multiforme is the most common malignant brain tumor in adults, with an average survival of less than one year due to its resistance to therapy. Recent studies reported that GBM initiates from CD133-expressing cancer stem cells (CSC). However, the efficacy of CSC targeting is limited. A...
Autores principales: | Kang, Tae-Wook, Choi, Soon Won, Yang, Se-Ran, Shin, Tae-Hoon, Kim, Hyung-Sik, Yu, Kyung-Rok, Hong, In-Sun, Ro, Seonggu, Cho, Joong Myung, Kang, Kyung-Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080225/ https://www.ncbi.nlm.nih.gov/pubmed/24989033 http://dx.doi.org/10.1038/srep05546 |
Ejemplares similares
-
Nogo receptor–vimentin interaction: a novel mechanism for the invasive activity of glioblastoma multiforme
por: Kang, Yun Hee, et al.
Publicado: (2019) -
The small molecule SI113 synergizes with mitotic spindle poisons in arresting the growth of human glioblastoma multiforme
por: Abbruzzese, Claudia, et al.
Publicado: (2017) -
Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012) -
GARP as an Immune Regulatory Molecule in the Tumor Microenvironment of Glioblastoma Multiforme
por: Zimmer, Niklas, et al.
Publicado: (2019) -
Inhibition of HIF1α and PDK Induces Cell Death of Glioblastoma Multiforme
por: Han, Jiwon Esther, et al.
Publicado: (2017)